TalkMed CEO suspended for eight months
Add BT as a preferred sourcePROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
Share with us your feedback on BT's products and services
TRENDING NOW
Singapore at 61: How we can ensure opportunity, security and ownership for the next generation
The S$1 million National Day paradox: ‘money dysmorphia’ amid a wealth surge
Over 2.4 million adult Singaporeans to get special S$400-S$600 cash payment in September
Why Asean matters more than ever to the UK and Singapore
